Skip to main content
. Author manuscript; available in PMC: 2017 Feb 5.
Published in final edited form as: J Surg Oncol. 2016 Dec 14;115(2):116–121. doi: 10.1002/jso.24418

TABLE II.

Baseline Characteristics of Premenopausal Patients Diagnosed With Stages I–III ER+ and/or PR+ Breast Cancer Between 2007 and 2012, Advised to Take Adjuvant Tamoxifen (n =515)

Demographics for patients in the post-oncofertility program cohort from 2007 to 2012
Characteristic No. of patients % of total cohort
Age at diagnosis (years)
 <37 127 24.7
 >37 388 75.3
Median age
Race/ethnicity
 White 363 70.5
 Black 63 12.2
 Hispanic 39 7.6
 Asian 38 7.4
 Other 10 1.9
 Missing 2 0.4
Marital status
 Unmarried 182 35.3
 Married, partnered, domestic partner 333 64.7
 Missing 0 0.0
Smoking status
 Current smoker 38 7.4
 Never smoker 365 70.9
 Former smoker 108 21.0
 Missing 4 0.8
Alcohol use
 None or <1 drink per week 242 47.0
 1–4 drinks per week 188 36.5
 5–9 drinks per week 59 11.5
 10–19 drinks per week 16 3.1
 >19 drinks per week 4 0.8
 Missing 6 1.2
Parity
 Nulliparous 196 38.1
 Parity >1 312 60.6
 Missing 7 1.4
Insurance status
 Private insurance 445 86.4
 Public insurance/uninsured 70 13.6
Fertility concerns
 Desires future fertility at diagnosis 112 21.7
 Does not express fertility concerns at diagnosis 403 78.3
Surgery
 Mastectomy 272 52.8
 Lumpectomy 240 46.6
 Axillary dissection only 1 0.2
 No surgery 2 0.4
Chemotherapy (among patients w/stage >1)
 No 121 29.1
 Yes 295 70.9
Radiation
 Patient declined 36 7.0
 Yes 355 68.9
 XRT not indicated 124 24.1
Stage
 0 99 19.2
 I 156 30.3
 II 183 35.5
 III 77 15.0